Diabetes Clinical Trials

Showing 7061-7080 of 7,874 trials

Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine

NCT00656422

The main objective of this clinical trial is to investigate hepatic fat as the primary endpoint along with body fat, and weight changes after initiation of a basal insulin therapy together with data acquisition that is today's standard in studies investigating obesity and eating patterns with insulin detemir and insulin glargine.

DiabetesObesity

University Hospital Tuebingen66 participantsStarted Nov 2007

Graz, Austria • Graz, Austria • Vienna, Austria +2 more locations

COMPLETEDPhase 2

Stem Cell Mobilization in Diabetic Neuropathy Subjects Receiving SB-509

NCT00665145

The primary and secondary objectives of this study are: Primary: To evaluate stem-cell-mobilization in subjects with diabetic neuropathy receiving SB-509. Stem cell mobilization will be assessed by evaluating the presence of stem cells circulating in peripheral blood. Secondary: To evaluate the safety of SB-509 in subjects treated with SB-509 with diabetic neuropathy; and to compare the effect of SB-509 versus placebo on a pre-defined multi-endpoint analysis that includes visual analog scale for pain intensity (VASPI), total neuropathy score (TNS), evoked nerve conduction velocity (NCV) and quantitative sensory testing (QST)

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic Polyneuropathy

Sangamo Therapeutics23 participantsStarted Jan 2008

La Jolla, California, United States • Walnut Creek, California, United States • Houston, Texas, United States +1 more locations

Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine

Stem Cell Mobilization in Diabetic Neuropathy Subjects Receiving SB-509

Related Searches

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes

Exercise and Glycemic Control in Type 2 Diabetes

Effect of a Fibrate and a Statin on Endothelial Dysfunction

Mobile Phone Applications and Quality of Life

Follow-Up Study for Exubera

Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin Secretion

VA Diabetes Prevention: Epidemiology of Pre-Diabetes and Implementation Pilot

Mechanisms of Glucose Lowering Effect of Colesevelam HCl

Vitamin D Inadequacy is Associated With Incidence of Type 2 Diabetes

Fluid Resuscitation for Pediatric Diabetic Ketoacidosis

The Acute Effect of Malt Extract Versus Sucrose on the Response of Glucose and Insulin, Subjective Appetite Sensations and ad Libitum Energy Intake

Evaluation of Insulin Glargine in Combination With Sitagliptin in Type 2 Diabetes Patients: EASIE Extension Trial

Health2006 - an Observational Study of Cardiovascular Disease, Diabetes, Asthma and Allergy

Lifestyle Intervention in a General Population for Prevention of Ischaemic Heart Disease

Pharmacokinetic Profile of Two Formulations of PB1023 Following Single Subcutaneous Injection in Subjects With Type 2 Diabetes Mellitus

Vildagliptin and the Glucagon Response to Hypoglycemia in Type 1 Diabetes

Virtual World Health Behavior Counseling for Patients With Diabetes